D Mulherin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D Mulherin

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Rheumatology (Oxford, England)|August 2, 2007

Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centresN Smith, K Gadsby, S Butt, et al.

Rheumatology (Oxford, England)|November 23, 2007

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.

Rheumatology (Oxford, England)|June 6, 2008

The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Rheumatology (Oxford, England)|August 2, 2007

Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centresN Smith, K Gadsby, S Butt, et al.

Rheumatology (Oxford, England)|November 23, 2007

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.

Rheumatology (Oxford, England)|June 6, 2008

The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.

Pageof 5